Phil Noland Roberts's most recent trade in Immunome Inc was a trade of 275,000 Stock option (right to buy) done . Disclosure was reported to the exchange on Dec. 13, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Phil Noland Roberts | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 275,000 | 275,000 | - | - | Stock option (right to buy) |